Kenneth M. Wells - Concepedia

Author

Kenneth M. Wells

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Abelmann, Nancy, K. M. WELLS, K. M. Wells, K.M. Wells, Kenneth M. Wells, Kenneth M Wells, Kenneth M. Wells, Kenneth Wells, Wells, Kenneth M., Wells, Kenneth Maurice

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Johnson & Johnson (United States)Janssen (United States)GlaxoSmithKline (United States)

About

Kenneth M. Wells is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.4K
2	Natural Sciences	10	10	545
3	Engineering	4	4	95
4	Law	2	2	42
5	Public Health	1	1	786

Kenneth M. Wells

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health Care Kenneth M. Wells, Ruth Klap, Alan K. Koike, American Journal of Psychiatry EthnicityHealth Care DisparitySubstance UseDrug AbuseRecent Policy	2001	786
Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524 David Askin, Kan K. Eng, Kai Rossen, Tetrahedron Letters Diastereoselective ReactionMedicinal Chemistry-Glycidyl TosylateBioorganic ChemistryNon-racemic Amide Enolate	1994	149
Do Physicians' Implicit Views of African Americans Affect Clinical Decision Making? M. N. Oliver, Kenneth M. Wells, Jennifer A. Joy-Gaba, The Journal of the American Board of Family Medicine	2014	146
Synthesis of an Anti-Methicillin-Resistant <i>Staphylococcus aureus </i>(MRSA) Carbapenem via Stannatrane-Mediated Stille Coupling Mark S. Jensen, Chunhua Yang, Yi Hsiao, Organic Letters Medicinal ChemistryAntimicrobial Drug DiscoveryNatural Product SynthesisCross-coupling ReactionBiochemistry	2000	84
An Efficient Synthesis of an α<sub>v</sub>β<sub>3</sub> Antagonist Nobuyoshi Yasuda, Yi Hsiao, Mark S. Jensen, The Journal of Organic Chemistry Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryBioorganic Chemistry	2004	70
In Vivo Characterization of a Dual Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonist in Animal Models of Parkinson’s Disease Brian C. Shook, Stefanie Rassnick, Melville C. Osborne, Journal of Medicinal Chemistry Dual Adenosine AReceptor AntagonistPharmacotherapyExperimental PharmacologyMedicinal Chemistry	2010	54
High-Throughput Automated Design of Experiment (DoE) and Kinetic Modeling to Aid in Process Development of an API Christopher J. Nunn, Andrew DiPietro, Neil S. Hodnett, Organic Process Research & Development EngineeringChemical AnalysisIndustrial EngineeringProcess DevelopmentSoftware Engineering	2017	51
Synthesis of the orally active spiroindoline-based growth hormone secretagogue, MK-677 Peter E. Maligres, Ioannis N. Houpis, Kai Rossen, Tetrahedron Medicinal ChemistryGrowth HormoneBiochemistryMedicineNatural Sciences	1997	49
Design and Characterization of Optimized Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonists for the Treatment of Parkinson's Disease Brian C. Shook, Stefanie Rassnick, Nathaniel Wallace, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural Sciences	2012	46
Preparation of crystallinep-nitrobenzyl 2-hydroxymethyl carbapenem as a key intermediate for the anti-MRS carbapenem L-786,392 Nobuyoshi Yasuda, Chunhua Yang, Kenneth M. Wells, Tetrahedron Letters Medicinal ChemistryKey IntermediateAnti-mrs Carbapenem L-786,392Natural SciencesOrganic Chemistry	1999	36

Page 1